John J. Lee

Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI-Bevacizumab Versus FOLFOX-Bevacizumab for Metastatic Colorectal Cancer (STEAM)

Herbert I. Hurwitz, Benjamin Tan, James A. Reeves et al. · The Oncologist · 2018 · 90 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001

Christian Marth, R. Tarnawski, Alexandra Tyulyandina et al. · International Journal of Gynecological Cancer · 2021 · 66 citations · Full text

Medicine, Oncology, Pharmacology +15

The murine equivalent of the A181E TACI mutation associated with common variable immunodeficiency severely impairs B-cell function

John J. Lee, Ingrid Rauter, Lilit Garibyan et al. · Blood · 2009 · 55 citations · Full text

Life Sciences, Genetics, Immunology +14

The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency

John J. Lee, Haifa H. Jabara, Lilit Garibyan et al. · Journal of Allergy and Clinical Immunology · 2010 · 54 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +12

Mapping language function with task-based vs. resting-state functional MRI

Ki Yun Park, John J. Lee, Donna Dierker et al. · PLoS ONE · 2020 · 53 citations · Full text

Medicine, Neuroscience, Surgery +15